Sonova H Ag - Asset Resilience Ratio
Sonova H Ag (SOON) has an Asset Resilience Ratio of 9.28% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Sonova H Ag debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2025)
This chart shows how Sonova H Ag's Asset Resilience Ratio has changed over time. See Sonova H Ag (SOON) shareholders funds for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Sonova H Ag's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SOON company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF500.50 Million | 9.09% |
| Short-term Investments | CHF10.50 Million | 0.19% |
| Total Liquid Assets | CHF511.00 Million | 9.28% |
Asset Resilience Insights
- Limited Liquidity: Sonova H Ag maintains only 9.28% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Sonova H Ag Industry Peers by Asset Resilience Ratio
Compare Sonova H Ag's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
MicroPort Endovascular MedTech Ltd
SHG:688016 |
Medical Devices | 2.16% |
|
Shandong Weigao Orthopaedic Device Co. Ltd. A
SHG:688161 |
Medical Devices | 6.18% |
|
Sino Medical Sciences Technology In
SHG:688108 |
Medical Devices | 0.66% |
|
Beijing Succeeder Technology Inc
SHG:688338 |
Medical Devices | 28.66% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 8.60% |
Annual Asset Resilience Ratio for Sonova H Ag (2005–2025)
The table below shows the annual Asset Resilience Ratio data for Sonova H Ag.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 3.80% | CHF225.40 Million ≈ $284.97 Million |
CHF5.92 Billion ≈ $7.49 Billion |
+3.80pp |
| 2024-03-31 | 0.01% | CHF400.00K ≈ $505.71K |
CHF5.79 Billion ≈ $7.32 Billion |
-0.02pp |
| 2023-03-31 | 0.03% | CHF1.40 Million ≈ $1.77 Million |
CHF5.55 Billion ≈ $7.02 Billion |
-2.69pp |
| 2022-03-31 | 2.72% | CHF151.90 Million ≈ $192.04 Million |
CHF5.59 Billion ≈ $7.06 Billion |
-20.09pp |
| 2021-03-31 | 22.81% | CHF1.35 Billion ≈ $1.71 Billion |
CHF5.93 Billion ≈ $7.49 Billion |
+22.74pp |
| 2020-03-31 | 0.07% | CHF3.30 Million ≈ $4.17 Million |
CHF4.49 Billion ≈ $5.67 Billion |
-1.36pp |
| 2019-03-31 | 1.44% | CHF61.70 Million ≈ $78.01 Million |
CHF4.29 Billion ≈ $5.43 Billion |
-1.75pp |
| 2018-03-31 | 3.19% | CHF137.34 Million ≈ $173.63 Million |
CHF4.30 Billion ≈ $5.44 Billion |
+1.06pp |
| 2017-03-31 | 2.13% | CHF83.91 Million ≈ $106.09 Million |
CHF3.94 Billion ≈ $4.98 Billion |
+2.06pp |
| 2016-03-31 | 0.07% | CHF1.92 Million ≈ $2.42 Million |
CHF2.75 Billion ≈ $3.48 Billion |
-0.13pp |
| 2015-03-31 | 0.20% | CHF5.45 Million ≈ $6.89 Million |
CHF2.69 Billion ≈ $3.40 Billion |
+0.05pp |
| 2014-03-31 | 0.15% | CHF3.97 Million ≈ $5.02 Million |
CHF2.59 Billion ≈ $3.28 Billion |
-0.02pp |
| 2013-03-31 | 0.17% | CHF4.64 Million ≈ $5.87 Million |
CHF2.68 Billion ≈ $3.39 Billion |
-0.12pp |
| 2012-03-31 | 0.30% | CHF6.80 Million ≈ $8.60 Million |
CHF2.29 Billion ≈ $2.89 Billion |
-1.02pp |
| 2011-03-31 | 1.32% | CHF28.59 Million ≈ $36.14 Million |
CHF2.17 Billion ≈ $2.75 Billion |
+0.59pp |
| 2010-03-31 | 0.73% | CHF17.55 Million ≈ $22.19 Million |
CHF2.41 Billion ≈ $3.05 Billion |
-0.30pp |
| 2009-03-31 | 1.03% | CHF14.66 Million ≈ $18.54 Million |
CHF1.43 Billion ≈ $1.80 Billion |
-0.24pp |
| 2008-03-31 | 1.27% | CHF16.19 Million ≈ $20.47 Million |
CHF1.27 Billion ≈ $1.61 Billion |
-3.79pp |
| 2007-03-31 | 5.07% | CHF64.00 Million ≈ $80.92 Million |
CHF1.26 Billion ≈ $1.60 Billion |
+3.69pp |
| 2006-03-31 | 1.38% | CHF12.76 Million ≈ $16.13 Million |
CHF928.12 Million ≈ $1.17 Billion |
-0.29pp |
| 2005-03-31 | 1.67% | CHF12.40 Million ≈ $15.68 Million |
CHF743.36 Million ≈ $939.81 Million |
-- |
About Sonova H Ag
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hea… Read more